LeMaitre Vascular (LMAT) president reports grants of dividend equivalent rights

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

LeMaitre Vascular (LMAT) President and Director David B. Roberts reported compensation-related grants of dividend equivalent rights on derivative awards. On March 26, 2026, he acquired multiple small blocks of Dividend Equivalent Rights, each economically equal to one share of common stock and priced at $0.0000 per right.

The footnotes explain these rights accrued on previously granted restricted stock units and performance share units from awards dated December 12, 2022, December 8, 2023, December 6, 2024, February 18, 2025, and December 10, 2025, and vest proportionately with those awards. No open‑market buys or sells were reported; this filing reflects routine equity-based compensation accrual rather than trading activity.

Insider Trade Summary

9 transactions reported

Mixed 9 txns

Insider Roberts David B

Role President and Director

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights	1.544	$0.00	--
Grant/Award	Dividend Equivalent Rights	1.544	$0.00	--
Grant/Award	Dividend Equivalent Rights	2.637	$0.00	--
Grant/Award	Dividend Equivalent Rights	3.16	$0.00	--
Grant/Award	Dividend Equivalent Rights	2.291	$0.00	--
Grant/Award	Dividend Equivalent Rights	2.596	$0.00	--
Grant/Award	Dividend Equivalent Rights	0.222	$0.00	--
Grant/Award	Dividend Equivalent Rights	0.251	$0.00	--
Grant/Award	Dividend Equivalent Rights	3.839	$0.00	--

Holdings After Transaction: Dividend Equivalent Rights — 21.518 shares (Direct)

Footnotes (1)

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Key Figures

Derivative transactions: 9 derivative entries Acquisition count: 9 acquisitions Largest rights grant: 3.8386 rights +3 more

6 metrics

Derivative transactions 9 derivative entries All on March 26, 2026 as grants of rights

Acquisition count 9 acquisitions transactionSummary acquireCount for Roberts

Largest rights grant 3.8386 rights Single Dividend Equivalent Rights grant on March 26, 2026

Example grant size 1.5436 rights Several individual Dividend Equivalent Rights grants

Exercise price $0.0000 per right Conversion or exercise price for the rights

Post-grant holding example 24.2949 rights Total Dividend Equivalent Rights following one transaction

Key Terms

Dividend Equivalent Rights, restricted stock unit, performance share unit, economic equivalent of one share, +1 more

5 terms

Dividend Equivalent Rights financial

"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock unit financial

"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Form 4 regulatory

"INSIDER FILING DATA (Form 4): {"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

03/30/2026 - 05:57 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roberts David B

(Last)

(First)

(Middle)

C/O LEMAITRE VASCULAR, INC.

63 SECOND AVENUE

(Street)

BURLINGTON

MASSACHUSETTS

01803

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Dividend Equivalent Rights	⁽¹⁾	03/26/2026		A		1.5436		⁽¹⁾	⁽¹⁾	Common Stock	1.5436	$0	21.5176	D
Dividend Equivalent Rights	⁽²⁾	03/26/2026		A		1.5436		⁽²⁾	⁽²⁾	Common Stock	1.5436	$0	20.8346	D
Dividend Equivalent Rights	⁽³⁾	03/26/2026		A		2.6368		⁽³⁾	⁽³⁾	Common Stock	2.6368	$0	23.5912	D
Dividend Equivalent Rights	⁽⁴⁾	03/26/2026		A		3.1596		⁽⁴⁾	⁽⁴⁾	Common Stock	3.1596	$0	24.2949	D
Dividend Equivalent Rights	⁽⁵⁾	03/26/2026		A		2.2914		⁽⁵⁾	⁽⁵⁾	Common Stock	2.2914	$0	11.6753	D
Dividend Equivalent Rights	⁽⁶⁾	03/26/2026		A		2.5959		⁽⁶⁾	⁽⁶⁾	Common Stock	2.5959	$0	11.9798	D
Dividend Equivalent Rights	⁽⁷⁾	03/26/2026		A		0.2217		⁽⁷⁾	⁽⁷⁾	Common Stock	0.2217	$0	1.4183	D
Dividend Equivalent Rights	⁽⁸⁾	03/26/2026		A		0.2509		⁽⁸⁾	⁽⁸⁾	Common Stock	0.2509	$0	1.4475	D
Dividend Equivalent Rights	⁽⁹⁾	03/26/2026		A		3.8386		⁽⁹⁾	⁽⁹⁾	Common Stock	3.8386	$0	3.8386	D

Explanation of Responses:

1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

2. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

4. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

6. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

7. These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

8. These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

9. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Laurie A. Churchill, Attorney-in-fact	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did LMAT President David B. Roberts report?

David B. Roberts reported grants of dividend equivalent rights, not open-market trades. These rights accrued on prior restricted stock unit and performance share unit awards and are economically equivalent to common shares, vesting proportionately with the underlying equity awards over time.

Were any LMAT shares bought or sold on the market in this Form 4?

No market purchases or sales were reported. All nine transactions involved derivative-type awards coded as grants of dividend equivalent rights at a price of $0.0000 per right, reflecting routine equity compensation accrual rather than discretionary trading in LMAT common stock.

What are dividend equivalent rights in the LMAT Form 4 filing?

Dividend equivalent rights give the holder economic value equal to LMAT common stock dividends. In this filing, each right is explicitly described as the economic equivalent of one share of common stock and accrues on outstanding restricted stock unit and performance share unit awards.

How many derivative grants were reported by LMAT insider David B. Roberts?

The Form 4 shows nine derivative transactions, all classified as acquisitions. Each entry reflects a small grant of dividend equivalent rights tied to earlier restricted stock unit or performance share unit awards, with no reported exercises, sales, gifts, or tax-withholding dispositions.

Which prior equity awards generated these LMAT dividend equivalent rights?

The dividend equivalent rights accrued on equity awards originally granted on December 12, 2022, December 8, 2023, December 6, 2024, February 18, 2025, and December 10, 2025. They vest proportionately with the corresponding restricted stock unit and performance share unit awards referenced in the footnotes.